In Incyte Corp. v. Sun Pharmaceutical Industries, the US Court of Appeals for the Federal Circuit dismissed an inter partes review (IPR) petitioner’s appeal of its Patent Trial and Appeal Board (PTAB) loss for lack of Article III standing, holding that neither its potential infringement liability nor the competitor standing doctrine established injury in fact sufficient to confer standing to appeal.
Source link
